Gene · 2173
Papers2,926
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,926
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular mechanism of circRNAs in drug resistance in renal cell carcinoma. | Cancer Cell Int | 2022 | 36424596 | PubTator, text mining | PubMed |
| Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma. | PLoS One | 2022 | 36417422 | PubTator, text mining | PubMed |
| Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape. | Elife | 2022 | 36412091 | PubTator, text mining | PubMed |
| Development of subdomains in the medial pallium of Xenopus laevis and Trachemys scripta: Insights into the anamniote-amniote transition. | Front Neuroanat | 2022 | 36406242 | PubTator, text mining | PubMed |
| Identification of a novel signature with prognostic value in triple-negative breast cancer through clinico-transcriptomic analysis. | Ann Transl Med | 2022 | 36388802 | PubTator, text mining | PubMed |
| Brain Regional Identity and Cell Type Specificity Landscape of Human Cortical Organoid Models. | Int J Mol Sci | 2022 | 36361956 | PubTator, text mining | PubMed |
| Exploring the Role of Lipid-Binding Proteins and Oxidative Stress in Neurodegenerative Disorders: A Focus on the Neuroprotective Effects of Nutraceutical Supplementation and Physical Exercise. | Antioxidants (Basel) | 2022 | 36358488 | PubTator, text mining | PubMed |
| Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition. | Pharmaceuticals (Basel) | 2022 | 36355506 | PubTator, text mining | PubMed |
A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy. | Investig Clin Urol | 2022 | 36347549 | PubTator, text mining | PubMed |
| Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer. | Front Genet | 2022 | 36338982 | PubTator, text mining | PubMed |
| [Role of fatty acid-binding protein 7 and novel therapeutic approach in synucleinopathies]. | Nihon Yakurigaku Zasshi | 2022 | 36328545 | PubTator, text mining | PubMed |
| Silk scaffolding drives self-assembly of functional and mature human brain organoids. | Front Cell Dev Biol | 2022 | 36313550 | PubTator, text mining | PubMed |
| Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain. | Development | 2022 | 36305490 | PubTator, text mining | PubMed |
| A multi-omics approach to visualize early neuronal differentiation from hESCs in 4D. | iScience | 2022 | 36304110 | PubTator, text mining | PubMed |
| Prenatal exposure to inflammation increases anxiety-like behaviors in F1 and F2 generations: possible links to decreased FABP7 in hippocampus. | Front Behav Neurosci | 2022 | 36299292 | PubTator, text mining | PubMed |
| Macrophage Phenotypes and Gene Expression Patterns Are Unique in Naturally Occurring Metabolically Healthy Obesity. | Int J Mol Sci | 2022 | 36293536 | PubTator, text mining | PubMed |
| Resistance to Trastuzumab. | Cancers (Basel) | 2022 | 36291900 | PubTator, text mining | PubMed |
| Emerging Role of Enhancer RNAs as Potential Diagnostic and Prognostic Biomarkers in Cancer. | Noncoding RNA | 2022 | 36287118 | PubTator, text mining | PubMed |
| Molecular diagnostics in neurotrauma: Are there reliable biomarkers and effective methods for their detection? | Front Mol Biosci | 2022 | 36250009 | PubTator, text mining | PubMed |
| SAR study on Novel truxillic acid monoester-Based inhibitors of fatty acid binding proteins as Next-Generation antinociceptive agents. | Bioorg Chem | 2022 | 36244323 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2173/papers?page=16